Vera Therapeutics, Inc.

While #NationalKidneyMonth winds down, our mission to advance kidney health keeps going! We're energized to connect with the global kidney health community and dive into the latest developments in #IgANephropathy research at #WCN. There’s one more day to visit us at Booth 15 and join us in advancing innovation in #nephrology! #KidneyHealth #IgAN

This week we’re heading to Yokohama for the International Society of Nephrology World Congress of Nephrology! We’re presenting three posters and sponsoring an industry session. Be sure to stop by Booth 15 to connect, swap insights, and be part of the conversation. #ISNWCN #NationalKidneyMonth 

We're pleased to welcome Jane Wright-Mitchell as Chief Legal Officer! Read more: https://lnkd.in/eVhTnfRG

As we continue to recognize #NationalKidneyMonth, we're sharing a plain-language summary of results from our recent clinical trial in #IgANephropathy, published in Current Medical Research and Opinion. We're committed to making complex trial findings more easily understood. Read more: https://lnkd.in/e32cpJgW

This #NationalKidneyMonth, we're highlighting the importance of awareness and information for those living with or affected by #IgANephropathy and other kidney diseases. We’re committed to supporting the development of resources that can make a real difference in patients' lives. No matter where you are in your #IgAN journey, it’s important to learn as much as you can and monitor your condition. Explore a learning guide for IgAN and related conditions: https://lnkd.in/exHarwf8 #KidneyHealth

Today is World Kidney Day, a global moment to recognize kidney health as essential to overall wellbeing. Advances in kidney disease treatment are improving how we care for patients. Improved understanding of disease, new management strategies, and continued research are making a difference in patient outcomes and quality of life. This World Kidney Day, we recognize the importance of ongoing innovation and commitment to kidney health for all patients.  #KidneyHealthForAll #OurKidneysOurPlanet

We’re attending the 8th Annual Chronic Kidney Disease Drug Development Summit taking place March 16-18 in Boston. Don’t miss the presentation from Kerry Cooper, SVP of Medical Affairs, on March 17. View the full agenda: https://lnkd.in/e7vQYM7s

During #NationalKidneyMonth and #AutoimmuneAwarenessMonth, let's talk about a disease that has serious unmet need, yet remains largely unknown: #IgANephropathy. #IgAN is the most common primary glomerulonephritis worldwide. It's a chronic autoimmune kidney disease in which immune complexes containing IgA antibodies build up in the kidneys, causing inflammation and damage over time. IgAN is often clinically silent, with no obvious signs or symptoms in the early stages. Many patients don't realize they have kidney disease, and when finally diagnosed, significant irreversible loss of kidney function may have already occurred. This lack of awareness means many people don't understand their diagnosis or the importance of working with their healthcare team to manage it. This National Kidney Month, spread the word about IgAN and other autoimmune kidney diseases. Knowledge is the first step toward better outcomes. Learn more about IgAN: veratx.com/patients/

We’re excited to announce that Vera Therapeutics has appointed Christopher Hite to our Board of Directors. Chris is an accomplished executive with decades of corporate and financial strategy leadership in the biopharmaceutical sector. His strategic expertise will be invaluable as we work to advance transformative treatments for patients in need. Read more: https://lnkd.in/eEti_8M9

March is #NationalKidneyMonth, a time to recognize the importance of kidney health. We’re proud to partner with multiple advocacy groups that tirelessly work towards raising awareness of kidney disease, providing invaluable resources and support, and educating the community. You can find patient and caregiver resources at The IgA Nephropathy Foundation, National Kidney Foundation, NephCure, and World Kidney Day.